Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis

EMBO Journal

Volumn 31, Issue 17, 2012, Pages 3607-3619

  Laarman, Alexander J ^a   Mijnheer, Gerdien ^a   Mootz, Joe M ^b   Van Rooijen, Willemien J M ^a   Ruyken, Maartje ^a   Malone, Cheryl L ^b   Heezius, Erik C ^a   Ward, Richard ^c   Milligan, Graeme ^c   Van Strijp, Jos A G ^a   De Haas, Carla J C ^a   Horswill, Alexander R ^b   Van Kessel, Kok P M ^a   Rooijakkers, Suzan H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CXCR2; immune evasion; proteases; Staphylococcus aureus

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR2 ANTAGONIST; CYSTEINE PROTEINASE; STAPHOPAIN A; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL PROTEINS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYSTEINE ENDOPEPTIDASES; FEMALE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; NEUTROPHILS; RECEPTORS, INTERLEUKIN-8B; U937 CELLS;

MURINAE; STAPHYLOCOCCUS AUREUS;

EID: 84866061621     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2012.212     Document Type: Article

References (57)

1. Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25: 787-820
2. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR (2000) Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6: 1275-1277
3. Bae T, Schneewind O (2006) Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55: 58-63
4. Benson MA, Lilo S, Wasserman GA, Thoendel M, Smith A, Horswill AR, Fraser J, Novick RP, Shopsin B, Torres VJ (2011) Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol 81: 659-675
5. Bestebroer J, Poppelier MJJG, Ulfman LH, Lenting PJ, Denis CV, van Kessel KPM, van Strijp JAG, de Haas CJC (2007) Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 109: 2936-2943
6. Bestebroer J, van Kessel KP, Azouagh H, Walenkamp AM, Boer IG, Romijn RA, van Strijp JA, de Haas CJ (2009) Staphylococcal SSL5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 113: 328-337
7. Boles BR, Thoendel M, Roth AJ, Horswill AR (2010) Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS ONE 5: e10146
8. Cerretti DP, Nelson N, Kozlosky CJ, Morrissey PJ, Copeland NG, Gilbert DJ, Jenkins NA, Dosik JK, Mock BA (1993) The murine homologue of the human interleukin-8 receptor type B maps near the Ity-Lsh-Bcg disease resistance locus. Genomics 18: 410-413
9. Chuntharapai A, Lee J, Hebert CA, Kim KJ (1994) Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 53: 5682-5688
10. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, van Wamel WJ, Heezius EC, Poppelier MJ, van Kessel KP, van Strijp JA (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199: 687-695
11. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F (2006) Complete genome sequence of US A300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 367: 731-739
12. Dubin G, Stec-Niemczyk J, Kisielewska M, Pustelny K, Popowicz GM, Bista M, Kantyka T, Boulware KT, Stennicke HR, Czarna A, Phopaisarn M, Daugherty PS, Thøgersen IB, Enghild JJ, Thornberry N, Dubin A, Potempa J (2008) Enzymatic activity of the Staphylococcus aureus SplB serine protease is induced by substrates containing the sequence Trp-Glu-Leu-Gln. J Mol Biol 379: 343-356
13. Eisele NA, Lee-Lewis H, Besch-Williford C, Brown CR, Anderson DM (2011) Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague. Am J Pathol 178: 1190-1200
14. Filipek R, Rzychon M, Oleksy A, Gruca M, Dubin A, Potempa J, Bochtler M (2003) The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. J Biol Chem 278: 40959-40966
15. Geisbrecht BV (2008) Staphylococcal complement inhibitors: biological functions, recognition of complement components, and potential therapeutic implications. Adv Exp Med Biol 632: 221-236
16. Golonka E, Filipek R, Sabat A, Sinczak A, Potempa J (2004) Genetic characterization of staphopain genes in Staphylococcus aureus. Biol Chem 385: 1059-1067
17. Gray GD, Hasslen SR, Ember JA, Carney DF, Herron MJ, Erlandsen SL, Nelson RD (1997) Receptors for the chemoattractants C5a and IL-8 are clustered on the surface of human neutrophils. J Histochem Cytochem 45: 1461-1467
18. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman JW, Mack M, Reutershan J, Briles DE, Paton JC, Winter C, Welte T, Maus UA (2010) Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection. Infect Immun 78: 2620-2630
19. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI (1991) Structure and functional expression of a human interleukin-8 receptor. Science 253: 1278-1280
20. Huth JR, Bewley CA, Jackson BM, Hinnebusch AG, Clore GM, Gronenborn AM (1997) Design of an expression system for detecting folded protein domains and mapping macromolecular interactions by NMR. Protein Sci 6: 2359-2364
21. Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J (2005) Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 201: 1669-1676
22. Jones RC, Deck J, Edmondson RD, Hart ME (2008) Relative quantitative comparisons of the extracellular protein profiles of Staphylococcus aureus UAMS-1 and its sarA, agr, and sarA agr regulatory mutants using one-dimensional polyacrylamide gel electrophoresis and nanocapillary liquid chromatography coupled with tandem mass spectrometry. J Bacteriol 190: 5265-5278
23. Jongerius I, Köckritz-Blickwede von M, Horsburgh MJ, Ruyken M, Nizet V, Rooijakkers SHM (2012) Staphylococcus aureus virulence is enhanced by secreted factors that block innate immune defenses. J Innate Immun 4: 301-311
24. Kalińska M, Kantyka T, Greenbaum DC, Larsen KS, Wadyka B, Jabaiah A, Bogyo M, Daugherty PS, Wysocka M, Jaros M, Lesner A, Rolka K, Schaschke N, Stennicke H, Dubin A, Potempa J, Dubin G (2012) Substrate specificity of Staphylococcus aureus cysteine proteases\Staphopains A, B and C. Biochimie 94: 318-327
25. Katancik JA, Sharma A, Radel SJ, De NE (1997) Mapping of the extracellular binding regions of the human interleukin-8 type B receptor. Biochem Biophys Res Commun 232: 663-668
26. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, Deleo FR (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202: 1050-1058
27. Kew RR, Peng T, DiMartino SJ, Madhavan D, Weinman SJ, Cheng D, Prossnitz ER (1997) Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemo-tactic mechanisms and receptor structure/function relationships. J Leukoc Biol 61: 329-337
28. Kiedrowski MR, Kavanaugh JS, Malone CL, Mootz JM, Voyich JM, Smeltzer MS, Bayles KW, Horswill AR (2011) Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS ONE 6: e26714
29. Laarman AJ, Ruyken M, Malone CL, van Strijp JA, Horswill AR, Rooijakkers SH (2011) Staphylococcus aureus metalloprotease aureolysin cleaves Complement C3 to mediate immune evasion. J Immunol 186: 6445-6453
30. Lin Y, Anderson MJ, Kohler PL, Strandberg KL, Olson ME, Horswill AR, Schlievert PM, Peterson ML (2011) Proinflammatory exopro-tein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry 50: 7157-7167
31. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532
32. Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043
33. Nickerson N, Ip J, Passos DT, Mcgavin MJ (2010) Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC. Mol Microbiol 75: 161-177
34. Norgauer J, Metzner B, Schraufstatter I (1996) Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J Immunol 156: 1132-1137
35. Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, Nishimura Y, Shinohara M, Imamura T (2011) Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology 157: 786-792
36. Otto HH, Schirmeister T (1997) Cysteine proteases and their inhibitors. Chem Rev 97: 133-172
37. Potempa J, Dubin A, Korzus G, Travis J (1988) Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem 263: 2664-2667
38. Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1: 70-87
39. Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP (2006) A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. J Immunol 177: 8017-8026
40. Prat C, Haas PJ, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP (2009) A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. J Immunol 183: 6569-6578
41. Prokesova L, Potuznikova B, Potempa J, Zikan J, Radl J, Hachova L, Baran K, Porwit-Bobr Z, John C (1992) Cleavage of human immunoglobulins by serine proteinase from Staphylococcus aur-eus. Immunol Lett 31: 259-265
42. Rooijakkers SHM, van Kessel KPM, van Strijp JAG (2005) Staphylococcal innate immune evasion. Trends Microbiol 13: 596-601
43. Rzychon M, Sabat A, Kosowska K, Potempa J, Dubin A (2003) Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases. Mol Microbiol 49: 1051-1066
44. Schenk S, Laddaga RA (1992) Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett 73: 133-138
45. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365: 654-657
46. Shaw L, Golonka E, Potempa J (2004) The role and regulation of the extracellular proteases of Staphylococcus aureus. Microbiology 150: 217-228
47. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48: 4673-4679
48. Smagur J, Guzik K, Bzowska M, Kuzak M, Zarebski M, Kantyka T, Walski M, Gajkowska B, Potempa J (2009a) Staphylococcal cysteine protease staphopain B (SspB) induces rapid engulfment of human neutrophils and monocytes by macrophages. Biol Chem 390: 361-371
49. Smagur J, Guzik K, Magiera L, Bzowska M, Gruca M, Thogersen IB, Enghild JJ, Potempa J (2009b) A new pathway of staphylococcal pathogenesis: apoptosis-like death induced by Staphopain B in human neutrophils and monocytes. J Innate Immun 1: 98-108
50. Tateda K, Moore TA, Newstead MW, Tsai WC, Zeng X, Deng JC, Chen G, Reddy R, Yamaguchi K, Standiford TJ (2001) Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunor-egulatory cells. Infect Immun 69: 2017-2024
51. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ (2000) CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun 68: 4289-4296
52. Van den Berg S, van Wamel WJB, Snijders SV, Ouwerling B, de Vogel CP, Boelens HA, Willems RJL, Huijsdens XW, Verreck FAW, Kondova I, Heidt PJ, Verbrugh HA, van Belkum A (2011) Rhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineages. PLoS ONE 6: e26170
53. Wang R, Braughton KR, Kretschmer D, Bach T-HL, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, Deleo FR, Otto M (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13: 1510-1514
54. Walenkamp AM, Boer IG, Bestebroer J, Rozeveld D, Timmer-Bosscha H, Hemrika W, van Strijp JA, de Haas CJ (2009) Staphylococcal superantigen-like 10 inhibits CXCL12-induced human tumor cell migration. Neoplasia 11: 333-344
55. Wilson S, Wilkinson G, Milligan G (2005) The CXCR1 and CXCR2 receptors form constitutive homo-and heterodimers selectively and with equal apparent affinities. JBiol Chem 280: 28663-28674
56. Wörmann ME, Reichmann NT, Malone CL, Horswill AR, Gründling A (2011) Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J Bacteriol 193: 5279-5291
57. Wuyts A, Van ON, Haelens A, Samson I, Herdewijn P, Ben-Baruch A, Oppenheim JJ, Proost P, Van DJ (1997) Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36: 2716-2723